KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $25.3 million.

  • Charles River Laboratories International's Consolidated Net Income fell 20.97% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 118.60%. This contributed to the annual value of $25.3 million for FY2024, which is 94.74% down from last year.
  • Per Charles River Laboratories International's latest filing, its Consolidated Net Income stood at $25.3 million for FY2024, which was down 94.74% from $480.4 million recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Consolidated Net Income registered a high of $492.6 million during FY2022, and its lowest value of $25.3 million during FY2024.
  • Moreover, its 3-year median value for Consolidated Net Income was $480.4 million (2023), whereas its average is $332.8 million.
  • Per our database at Business Quant, Charles River Laboratories International's Consolidated Net Income soared by 43.79% in 2020 and then slumped by 94.74% in 2024.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Consolidated Net Income stood at $365.3 million in 2020, then grew by 9.18% to $398.8 million in 2021, then climbed by 23.51% to $492.6 million in 2022, then declined by 2.48% to $480.4 million in 2023, then slumped by 94.74% to $25.3 million in 2024.